JP2021525242A5 - - Google Patents

Info

Publication number
JP2021525242A5
JP2021525242A5 JP2020565331A JP2020565331A JP2021525242A5 JP 2021525242 A5 JP2021525242 A5 JP 2021525242A5 JP 2020565331 A JP2020565331 A JP 2020565331A JP 2020565331 A JP2020565331 A JP 2020565331A JP 2021525242 A5 JP2021525242 A5 JP 2021525242A5
Authority
JP
Japan
Prior art keywords
compound
formulation
parts kit
pharmaceutically
keratitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020565331A
Other languages
English (en)
Japanese (ja)
Other versions
JP7742226B2 (ja
JP2021525242A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2019/088593 external-priority patent/WO2019228307A1/en
Publication of JP2021525242A publication Critical patent/JP2021525242A/ja
Publication of JP2021525242A5 publication Critical patent/JP2021525242A5/ja
Application granted granted Critical
Publication of JP7742226B2 publication Critical patent/JP7742226B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020565331A 2018-05-28 2019-05-27 新たな医薬品使用 Active JP7742226B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2018/088701 2018-05-28
CN2018088701 2018-05-28
PCT/CN2019/088593 WO2019228307A1 (en) 2018-05-28 2019-05-27 New pharmaceutical use

Publications (3)

Publication Number Publication Date
JP2021525242A JP2021525242A (ja) 2021-09-24
JP2021525242A5 true JP2021525242A5 (enExample) 2022-06-06
JP7742226B2 JP7742226B2 (ja) 2025-09-19

Family

ID=68697381

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020565331A Active JP7742226B2 (ja) 2018-05-28 2019-05-27 新たな医薬品使用

Country Status (8)

Country Link
US (2) US20210196783A1 (enExample)
EP (1) EP3802562A4 (enExample)
JP (1) JP7742226B2 (enExample)
KR (1) KR20210016365A (enExample)
CN (1) CN112236440A (enExample)
MA (1) MA52794A (enExample)
TW (1) TW202016127A (enExample)
WO (1) WO2019228307A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115300508A (zh) * 2017-07-05 2022-11-08 艾缇亚(上海)制药有限公司 包含孟鲁司特与贻贝粘附蛋白的组合的局部制剂
MA54707A (fr) * 2019-01-10 2021-11-17 Jiangyin Mucocare Pharmaceutical Co Ltd Nouvelles formulations contenant des antagonistes des récepteurs des leucotriènes
CN114375298A (zh) 2019-09-14 2022-04-19 江阴贝瑞森制药有限公司 新肽
AU2020396109A1 (en) * 2019-12-02 2022-07-07 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. Peptides and their use in the treatment of inflammation
EP4228641A1 (en) * 2020-10-13 2023-08-23 Diomed Developments Limited Gel formulations comprising montelukast
WO2022193185A1 (en) * 2021-03-17 2022-09-22 Jiangyin Usun Pharmaceutical Co., Ltd. New conjugates
WO2022193186A1 (en) * 2021-03-17 2022-09-22 Jiangyin Usun Pharmaceutical Co., Ltd. New diagnostic and therapeutic agents
WO2024169972A1 (en) * 2023-02-13 2024-08-22 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. New multi-functional oligopeptides
WO2024260465A1 (en) 2023-06-22 2024-12-26 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. New multi-functional oligopeptides
TW202547549A (zh) 2024-03-20 2025-12-16 大陸商安利提沙（上海）製藥有限公司 源自血管活性腸肽的肽的新用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6100296A (en) * 1995-06-06 1996-12-24 Hemosphere, Inc. Protein particles for therapeutic and diagnostic use
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
US7833968B2 (en) * 2005-02-16 2010-11-16 The Regents Of The University Of California Pharmaceutical compositions for treating or preventing bone conditions
EP2101547B1 (de) 2008-03-11 2014-03-05 Vita Zahnfabrik H. Rauter GmbH & Co. KG Dental-Sinterofen sowie Verfahren zum Sintern keramischer Dental-Elemente
WO2011025158A2 (ko) * 2009-08-25 2011-03-03 포항공과대학교 산학협력단 홍합 접착 단백질 또는 이의 변이체에 음이온성 고분자가 포함된 코아세르베이트
ES2691070T3 (es) * 2012-05-11 2018-11-23 Kael-Gemvax Co.,Ltd Péptidos antiinflamatorios y composición que comprende los mismos
WO2014186937A1 (zh) * 2013-05-20 2014-11-27 Gao Min 贻贝粘蛋白凝胶的制备方法、贻贝粘蛋白凝胶及其应用
MX2018000333A (es) * 2015-07-20 2018-05-22 Bengt I Samuelsson Institute Of Life Science Res Producto de la proteina adhesiva de mejillon y las aplicaciones de este en la supresion de inflamaciones de la piel.
WO2017028025A1 (zh) * 2015-08-14 2017-02-23 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其抑制粘膜炎症的应用
WO2017181372A1 (zh) * 2016-04-20 2017-10-26 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其抑制血管炎症的应用
CN106581656A (zh) * 2016-12-30 2017-04-26 江阴贝瑞森生化技术有限公司 一种用于小儿舌舔皮炎的软膏
WO2019011286A1 (en) * 2017-07-14 2019-01-17 Jiangyin Usun Pharmaceutical Co., Ltd. ANTIVIRAL USE OF MEMBRANE ADHESIVE PROTEINS

Similar Documents

Publication Publication Date Title
JP2021525242A5 (enExample)
US20100113503A1 (en) Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
CN116785447B (zh) 孟鲁司特与肽的新缀合物
JP2022500437A5 (enExample)
US20160030452A1 (en) Minocycline Derivatives
AU2020203246A1 (en) Polymorphs of selinexor
US11518765B2 (en) Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases
RU2020121152A (ru) Твердые формы ингибитора калликреина плазмы и их соли
WO2003086407A1 (de) Verwendung von stimulatoren der löslichen guanylatcyclase zur behandlung von glaukom
JP2009510044A5 (enExample)
KR102892857B1 (ko) 케타민 파모에이트 및 이의 용도
CA2656858A1 (en) Positively charged water-soluble prodrugs of acetylsalicylic acid
JP2022502500A5 (enExample)
JP2024515829A5 (enExample)
JP2020503324A (ja) 慢性疼痛の処置のための組成物及び方法
JP2019529541A5 (enExample)
JP2025164962A (ja) ミトコンドリア病の治療のためのキノン類似体、ヒドロキノン類似体及びナフトキノン類似体
JP2019530674A5 (enExample)
JP2017522304A5 (enExample)
WO2006101858B1 (en) Alpha-helix mimetics and methods relating to the treatment of fibrosis
US20160243081A1 (en) Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease
CN110099681A (zh) 用于治疗口腔干燥症的组合物和方法
CN113272298A (zh) 用于治疗呼吸系统疾病的化合物和组合物
WO2024088153A1 (zh) 托品酸及其衍生物在制备治疗银屑病药物中的用途
JP2022500445A5 (enExample)